PTC Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTCT research report →
About the company
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications.
- CEO
- Matthew Klein
- IPO
- 2013
- Employees
- 939
- HQ
- Warren, NJ, US
Price Chart
- Market Cap
- $6.91B
- P/E
- -35.69
- P/S
- 8.36
- P/B
- -38.10
- EV/EBITDA
- -54.13
- Div Yield
- 0.00%
- Gross Margin
- 77.84%
- Op Margin
- -8.18%
- Net Margin
- -22.58%
- ROE
- 99.84%
- ROIC
- -2.38%
- Revenue
- $1.73B · 114.51%
- Net Income
- $682.64M · 287.90%
- EPS
- $8.58 · 281.40%
- Op Income
- $856.51M
- FCF YoY
- 486.03%
- 52W High
- $87.50
- 52W Low
- $43.17
- 50D MA
- $73.04
- 200D MA
- $71.38
- Beta
- 0.53
- Avg Volume
- 1.72M
Get TickerSpark's AI analysis on PTCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Almstead Neil Gregory | other | 7,718 |
| Jun 26, 26 | Almstead Neil Gregory | other | 412 |
| Jun 26, 26 | Almstead Neil Gregory | sell | 412 |
| Jun 26, 26 | Almstead Neil Gregory | sell | 7,718 |
| Jun 26, 26 | Almstead Neil Gregory | other | 412 |
| Jun 26, 26 | Almstead Neil Gregory | other | 7,718 |
| Jun 25, 26 | Almstead Neil Gregory | other | 19,859 |
| Jun 25, 26 | Almstead Neil Gregory | sell | 8,522 |
| Jun 24, 26 | Almstead Neil Gregory | other | 4,922 |
| Jun 25, 26 | Almstead Neil Gregory | other | 1,001 |
Our PTCT coverage
Recent articles, reports, and earnings notes.
No research on PTCT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTCT report →Similar companies
Peers in the same neighborhood.